Zevra Therapeutics Return on Net Operating Assets Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.94 +0.13 (+1.48%) USD | NASDAQ | Dec 31, 14:22

View Return on Net Operating Assets for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

XOMA Royalty Corp.	Upgrade
Akebia Therapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade

Return on Equity	Upgrade
Return on Assets	Upgrade
Return on Invested Capital	Upgrade
Profit Margin (Quarterly)	Upgrade
Gross Profit Margin (Quarterly)	Upgrade
Operating Margin (Quarterly)	Upgrade